nach oben

Journal of Neuro-Oncology

Erschienen in:

16.08.2016 | Topic Review

Prognostic role of microRNA-21 expression in gliomas: a meta-analysis

verfasst von: Chao Li, Jianjun Sun, Qian Xiang, Yan Liang, Nan Zhao, Zhuo Zhang, Qianxin Liu, Yimin Cui

Erschienen in: Journal of Neuro-Oncology | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

MicroRNA-21 (miRNA-21) has recently been shown to be a promising prognostic tumor biomarker. However, few studies have not supported this idea and have shown inconsistent data. Thus, we conducted a meta-analysis to elucidate the predictive value of miRNA-21 in gliomas. The relevant studies were identified by performing online search in PubMed, EMBASE and Web of Science databases up to Apr 2016. This meta-analysis study included seven eligible studies, consisting of 1121 gliomas and 533 glioblastoma multiforme (GBM) patients. Heterogeneity between studies was assessed using Egger’s and Begg’s test. Hazard ratios (HRs) with 95 % confidence intervals (CIs) for overall survival (OS), which compared the expression levels of miRNA-21 in patients with gliomas, were extracted and estimated. Our analysis revealed that the high expression of miRNA-21 is associated with the worse OS in gliomas. Further subgroup analysis indicated that increased expression of miRNA-21 was also associated with OS in GBM patients. Moreover, we observed a correlation between miRNA-21 expression and the World Health Organization defined gliomas grading system (WHO grade). Besides, high miRNA-21 expression was significantly correlated with lowered OS both in the Asian group and non-Asian group. In the cut-off subgroup analysis, both mean cut off value and median cut off value were significantly associated with OS. The expression level of miRNA-21 was not high in low KPS (Karnofsky score) group. miRNA-21 appears to be a promising biomarker for predicting the progression of patients with gliomas or GBM. However, due to the limited sample size, further prospective or retrospective multi-center well designed studies with adequate sample size should be conducted to verify its definite prognostic value.

Goodenberger ML, Jenkins RB (2012) Genetics of adult glioma. Cancer Genet 205(12):613–621PubMedCrossRef

Dolecek TA, Propp JM, Stroup NE et al (2012) CBTRUS statistical report: primary brain andcentral nervous system tumors diagnosed in the United States in 2005–2009. Neuro Oncol. doi:10.1093/neuonc/nos218

van den Bent MJ, Kros JM (2007) Predictive and prognostic markers in neuro-oncology. J Neuropathol Exp Neurol 66(12):1074–1081PubMedCrossRef

Dellaretti M, Reyns N, Touzet G et al (2012) Diffuse brainstem glioma: prognostic factors: clinical article. J Neurosurg.117(5):810–814PubMedCrossRef

Johnson DR, Galanis E (2013) Incorporation of prognostic and predictive factors into glioma clinical trials. Curr Oncol Rep 15(1):56–63PubMedCrossRef

Kwak HJ, Kim YJ, Chun KR et al (2011) Downregulation of Spry2 by miR-21 triggers malignancy in human gliomas. Oncogene 30(21):2433–2442PubMedCrossRef

Li WQ, Yu HY, Li YM et al (2014) Higher LRRFIP1 expression in glioblastoma multiforme is associated with better response to teniposide, a type II topoisomerase inhibitor. Biochem Biophys Res Commun 446(4):1261–1267PubMedCrossRef

Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281–297PubMedCrossRef

Lim LP, Lau NC, Garrett-Engele P et al (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433(7027):769–773PubMedCrossRef

10.

Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6(11):857–866PubMedCrossRef

11.

Nana-Sinkam P, Croce CM (2010) MicroRNAs in diagnosis and prognosis in cancer: what does the future hold? Pharmacogenomics 11(5):667–669PubMedCrossRef

12.

Krichevsky AM, Gabriely G (2009) MiR-21: a small multi-faceted RNA. J Cell Mol Med 13(1):39–53PubMedCrossRef

13.

Volinia S, Calin GA, Liu CG et al (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA. 103(7):2257–2261PubMedPubMedCentralCrossRef

14.

Hatley ME, Patrick DM, Garcia MR et al (2010) Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. Cancer Cell 18(3):282–293PubMedPubMedCentralCrossRef

15.

Chan JA, Krichevsky AM, Kosik KS (2005) MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65(14):6029–6033PubMedCrossRef

16.

Folini M, Gandellini P, Longoni N et al (2010) MiR-21: an oncomir on strike in prostate cancer. Mol Cancer 9:12PubMedPubMedCentralCrossRef

17.

Conti A, Aguennouz M, La Torre D et al (2009) miR-21 and 221 upregulation and miR-181b downregulation in human grade II–IV astrocytic tumors. J Neurooncol 93(3):325–332PubMedCrossRef

18.

Ho CY, Bar E, Giannini C, Marchionni L et al (2013) MicroRNA profiling in pediatric pilocytic astrocytoma reveals biologically relevant targets, including PBX3, NFIB, and METAP2. Neuro Oncol 15(1):69–82

19.

Barbano R, Palumbo O, Pasculli B et al (2014) A miRNA signature for defining aggressive phenotype and prognosis in gliomas. PLoS One 9(10):e108950PubMedPubMedCentralCrossRef

20.

Hermansen SK, Dahlrot RH, Nielsen BS et al (2013) MiR-21 expression in the tumor cell compartment holds unfavorable prognostic value in gliomas. J Neurooncol 111(1):71–81PubMedCrossRef

21.

Childs G, Fazzari M, Kung G, Kawachi N et al (2009) Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. Am J Pathol 174(3):736–745PubMedPubMedCentralCrossRef

22.

Heneghan HM, Miller N, Kelly R et al (2010) Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease. Oncologist 15(7):673–682PubMedPubMedCentralCrossRef

23.

Song J, Bai Z, Zhang J et al (2013) Serum microRNA-21 levels are related to tumor size in gastric cancer patients but cannot predict prognosis. Oncol Lett 6:1733–1737PubMedPubMedCentral

24.

Li G, Zhang Z, Tu Y et al (2013) Correlation of microRNA-372 up regulation with poor prognosis in human glioma. Diagn Pathol 8:1PubMedPubMedCentralCrossRef

25.

Maachani UB, Tandle A, Shankavaram U et al (2015) Modulation of miR-21 signaling by MPS1 in human glioblastoma. Oncotarget. doi:10.18632/oncotarget.4143

26.

Wu L, Li G, Feng D, Qin H et al (2013) MicroRNA-21 expression is associated with overall survival in patients with glioma. Diagn Pathol 8:200PubMedPubMedCentralCrossRef

27.

Stroup DF, Berlin JA, Morton SC et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (moose) group. JAMA 283:2008–2012PubMedCrossRef

28.

Tierney JF, Stewart LA, Ghersi D et al (2007) Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 8:16PubMedPubMedCentralCrossRef

29.

Zhi F, Chen X, Wang S et al (2010) The use of hsa-miR-21, hsa-miR-181b and hsa-miR-106a as prognostic indicators of astrocytoma. Eur J Cancer 46(9):1640–1649PubMedCrossRef

30.

Shi R, Wang PY, Li XY et al (2015) Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients. Oncotarget 6(29):26971–81PubMedPubMedCentralCrossRef

31.

Louis DN, Ohgaki H, Wiestler OD et al. (2007) WHO classification of tumours of the central nervous system, 4th edn. International Agency for Research on Cancer (IARC), Lyon

32.

Xia X, Yang B, Zhai X et al (2013) Prognostic role of microRNA-21 in colorectal cancer: a meta-analysis. PLoS One 8(11):e80426PubMedPubMedCentralCrossRef

33.

Yan LX, Huang XF, Shao Q et al (2008) MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 14(11):2348–2360PubMedPubMedCentralCrossRef

34.

Zhang JG, Wang JJ, Zhao F et al (2010) MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC). Clin Chim Acta 411:846–852PubMedCrossRef

35.

Lu Z, Liu M, Stribinskis V et al (2008) MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene 27(31):4373–4379PubMedCrossRef

36.

Meng F, Henson R, Wehbe-Janek H et al (2007) MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133(2):647–658PubMedPubMedCentralCrossRef

37.

Zhu S, Si ML, Wu H et al (2007) MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 282(19):14328–14336PubMedCrossRef

38.

Papagiannakopoulos T, Shapiro A, Kosik KS (2008) MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res 68(19): 8164–8172PubMedCrossRef

39.

Song B, Wang C, Liu J et al (2010) MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression. J Exp Clin Cancer Res 29:29PubMedPubMedCentralCrossRef

40.

Sarkar J, Gou D, Turaka P et al (2010) MicroRNA-21 plays a role in hypoxia-mediated pulmonary artery smooth muscle cell proliferation and migration. Am J Physiol Lung Cell Mol Physiol 299(6):L861–L871PubMedPubMedCentralCrossRef

41.

Iliopoulos D, Jaeger SA, Hirsch HA et al (2010) STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol Cell 39(4):493–506PubMedPubMedCentralCrossRef

42.

Dong Y, Sui L, Yamaguchi F et al (2010) Phosphatase and tensin homolog deleted on chromosome 10 regulates sensory cell proliferation and differentiation of hair bundles in the mammalian cochlea. Neuroscience 170(4):1304–1313PubMedCrossRef

43.

Gao Q, Zhang L, Zhang B et al (2014) Phosphatase and tensin homolog overexpression decreases proliferation and invasion and increases apoptosis in oral squamous cell carcinoma cells. Oncol Lett 8(3):1058–1064PubMedPubMedCentral

44.

Peters JM, Aoyama T, Cattley RC et al (1998) Role of peroxisome proliferator-activated receptor alpha in altered cell cycle regulation in mouse liver. Carcinogenesis 19(11):1989–1994CrossRef

45.

Gabriely G, Wurdinger T, Kesari S et al (2008 Sep) MicroRNA-21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol 28(17):5369–5380PubMedPubMedCentralCrossRef

46.

Gu L, Li H, Chen L, Ma X et al (2015) MicroRNAs as prognostic molecular signatures in renal cell carcinoma: a systematic review and meta-analysis. Oncotarget 6(32):32545–32560PubMedPubMedCentral

47.

Wang Y, Zhang Y, Pan C et al (2015) Prediction of poor prognosis in breast cancer patients based on microRNA-21 expression: a meta-analysis. PLoS One 10(2):e0118647PubMedPubMedCentralCrossRef

48.

Fu C, Dong W, Wang Z et al (2014) The expression of miR-21 and miR-375 predict prognosis of esophageal cancer. Biochem Biophys Res Commun 446(4):1197–1203PubMedCrossRef

49.

Xia XC, Yang BX, Zhai XG et al (2013) Prognostic role of microRNA-21 in colorectal cancer: a meta-analysis. Plos One 8:e80426PubMedPubMedCentralCrossRef

50.

Hayes DF, Isaacs C, Stearns V (2001) Prognostic factors in breast cancer: current and new predictors of metastasis. J Mammary Gland Biol Neoplasia 6:375–392PubMedCrossRef

51.

Huang RS, Gamazon ER, Ziliak D et al (2011) Population differences in microRNA expression and biological implications. Rna Biol 8:692–701PubMedPubMedCentralCrossRef

52.

Bleeker FE, Molenaar RJ, Leenstra S (2012) Recent advances in the molecular understanding of glioblastoma. J Neurooncol 108(1):11–27PubMedPubMedCentralCrossRef

Titel: Prognostic role of microRNA-21 expression in gliomas: a meta-analysis
verfasst von: Chao Li
Jianjun Sun
Qian Xiang
Yan Liang
Nan Zhao
Zhuo Zhang
Qianxin Liu
Yimin Cui
Publikationsdatum: 16.08.2016
Verlag: Springer US
Erschienen in: Journal of Neuro-Oncology / Ausgabe 1/2016
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-016-2233-7

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2016

Inhibition of STAT3 enhances the radiosensitizing effect of temozolomide in glioblastoma cells in vitro and in vivo

Predictive model for recovery of visual field after surgery of pituitary adenoma

Treatment of pediatric cerebral radiation necrosis: a systematic review

Altered tryptophan metabolism in human meningioma

Tumor infiltrating lymphocytes and PD-L1 expression in brain metastases of small cell lung cancer (SCLC)